Immune types can affect the success of liver cancer treatment

Freiburg/Heidelberg – Respective tumor microenvironment (TME) has already been discussed as a possible reason for different response rates of immune checkpoint inhibitors in hepatocellular carcinoma. Using high-resolution image mass cytometry, researchers from the University Hospitals in Freiburg and Heidelberg have now succeeded in identifying different cell types according to the respective…